Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Follow your internal laboratory handling and stability procedures after preparation
More than a checkup
(Explained for Non-Scientists) Think of your body like a construction site after an injury
US$ 20.12
US$ 28.39
US$ 24.86
US$ 26.79
US$ 28.06
US$ 22.65
US$ 20.90
US$ 21.65
